Skip to content
REGULATORY AFFAIRS

Post-market surveillance and PMCF

Post market surveillance is a crucial part of the medical device lifecycle. 

Post-market surveillance and post-market performance follow-up (PMCF)

Post market surveillance is a crucial part of the medical device lifecycle and is emphasized in both EU MDR 2017/745 and IVDR 2017/746.

The manufacturer’s Post Market Surveillance (PMS) system must proactively and systematically gather, record and analyze relevant data on the quality, performance, and safety of the medical device throughout its entire lifetime. As a Manufacturer you are obliged to collect and assess relevant information not only about your own device but also related devices from competitors.

We can compile the PMS Plan, carry out the scheduled activities and produce the PMS Report or Periodic Safety Update Report (PSUR). We monitor subsequent updates to device technical documentation, risk management, and labelling.

Post-Market Clinical Follow-up (PMCF) and Post-Market Performance Follow-up (PMPF)

A key piece of the PMS is also the Post-Market Clinical Follow-up (PMCF) for MDs and the Post-Market Performance Follow-up (PMPF) for IVDs, where manufacturers must systematically record and evaluate clinical data regarding the safety and performance of their device.

We can compile the PMCF or PMPF plan, perform the activities as scheduled, analyze and report the findings, support you in implementing any preventive or corrective measures, and update the clinical evaluation plan/report. When required for your implantable or Class III medical device, we draw up and update the Summary of Safety and Clinical Performance (SSCP). Global Registrations

We help streamline your market access.

Every medical device (MD and IVD) needs to be registered in a regulatory area or country before it can be sold. Each location has its own requirements and procedures: The EU has a different process than the US FDA and even within the EU, some medical devices need local acceptance. We have registered low and high-risk medical devices in the EU and in more than 60 countries worldwide.

Post-market activities services

We can support you with the following:

  • PMS procedures
  • PMCF/PMPF plans and reports
  • Collecting data/Literature review
  • Surveillance and assessment of upcoming changes in relevant standards and regulations
  • Training (customized or in open class)
  • Complaint and Vigilance handling (including FSCA/FSN)
female-entrepreneur-talking-colleague

Explore our services

labquality_com_32

Quality Management System ISO 13485

Setting up quality management systems (QMS) for medical device manufacturers.
labquality_com_22

US FDA 21 CFR Title 820 (QSR)

We know quality systems, including the USA Food and Drug Administration Quality System Regulation, QSR, 21 CFR Title 820.

labquality_com_21

QMS Improvement and Gap Analysis

Improvement of medical device manufacturer’s quality management system (QMS) and GAP analysis.

Contact us for more information

Meeri Säily
Meeri Säily
Sales Director

Leave a contact request

Latest news

Read the latest news from the world of quality.

QAdvis and Scandinavian CRO join Aurevia to strengthen clinical research and regulatory expertise

Scandinavian CRO (SCRO) and QAdvis will now operate under the name of Aurevia.

Meet us at ESCMID 2025 in Vienna

We will be at the ESCMID 11-15 April 2025 in Vienna, Austria.

Aurevia appoints Jonna Pelanti as the new Head of EQA business area

We are delighted to announce the appointment of the new Head of the EQA business area Jonna Pelanti.
Meet us at BioMedica in Dublin on 18-20 March.

Meet us at BioMedica in Dublin

Meet us at the BioMedica exhibition at booth A18!

Aurevia appoints Ulrika Hammarström as the new Head of CRO business area

We are delighted to announce the appointment of the new Head of the CRO business area Ulrika Hammarström.